Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
Conditions
Interventions
Intervention1: Wound dressing thin film impregnated with 5% Acalypha indica: 5% Acalypha indica, Applied topically over radiation dermatitis wounds on alternate days for 14 days
Control Intervention1:
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient willing to give written informed consent form 2. Newly diagnosed with non metastatic breast cancer and undergoing adjuvant radiation for breast cancer who develop grade III radiation therapy induced moist desquamation
Exclusion criteria
Exclusion criteria: 1.Patient unwilling to take part in study 2.Patients with contraindications for Radiation therapy 3.Patients with radiation skin reactions of severity less than Grade III 4.Patients with pre existing skin conditions such as psoriasis, eczema, or connective tissue disorders or history of allergy to components used in trial dressings 5.Patients on steroids or immunosuppressant therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess tolerance of Acalypha indica impregnated thin film on radiated tissue Timepoint: 4th to 6th week of radiation treatment for each patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess wound healing capacity of Acalypha indica impregnated thin film on radiation induced dermatitis wounds with respect to time taken for complete wound healing in comparison to gentian violet topical application. To assess improvement in quality of life of patientsTimepoint: Upto 6 months after completion of radiation protocol of last recruited patient | — |
Countries
India
Contacts
Public ContactJJayasutha
Sri Ramachandra Institute of Higher Education and Research (Deemed University)
Outcome results
None listed